Urovant Sciences Ltd (NASDAQ:UROV)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - UROV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - UROV

  • Market Cap$511.340m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINBMG9381B1081

Company Profile

Urovant Sciences Ltd is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's pipeline products include Overactive Bladder (OAB), OAB in Men with Benign Prostatic Hyperplasia (BPH), and IBS-Associated Pain.

Latest UROV news

Currently there for this company. Visit our news hub for other news .